RxDoctor Payments DataLook up a doctor →

CTL019_KYMRIAH_ONCOLOGY: payments to doctors

Payments that named CTL019_KYMRIAH_ONCOLOGY as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$15K
Providers
4
Transactions
11
Average per transaction
$1,350

The per-transaction average — $1,350 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 4 providers the average total is $3,712, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Novartis Pharma AG$14,847100.0%
← All drugs & devices